SCHEMBL31011900

SCHEMBL31011900

Cc1cccc2c1CCCCC2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.56
BAD Q92934 1/20 0.56
TSHR P16473 1/20 0.48
ALDH1A1 P00352 3/20 0.44
ALOX12 P18054 1/20 0.42
CES1 P23141 1/20 0.42
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
THRA P10827 1/20 0.41
THRB P10828 1/20 0.41
KMT2A Q03164 1/20 0.41
TBXA2R P21731 1/20 0.39
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5598514 1.00 BCL2L1 (0.56) BCL2L1BADTSHRALDH1A1ALOX12
SCHEMBL598625 0.98 BCL2L1 (0.58) BCL2L1BADTSHRALDH1A1ALOX12
SCHEMBL30717272 0.98 BCL2L1 (0.58) BCL2L1BADTSHRALDH1A1ALOX12
SCHEMBL29892288 0.93 BCL2L1 (0.52) BCL2L1BADTSHRALDH1A1ALOX12
SCHEMBL413550 0.93 BCL2L1 (0.52) BCL2L1BADTSHRALDH1A1ALOX12
Dimethylamine SCHEMBL6542165 0.89 BCL2L1 (0.50) BCL2L1BADTSHRALDH1A1ALOX12
SCHEMBL11352084 0.85
SCHEMBL6542200 0.81 ALDH1A1 (0.47) BCL2L1BADTSHRALDH1A1MEN1
O-Xylene SCHEMBL521796 0.80 TSHR (0.68) BCL2L1BADTSHRALDH1A1ALOX12
SCHEMBL19684557 0.78 PNMT (0.47) BCL2L1BADMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239792-A1 MODULATORS OF BCL-2 OR BCL-2/BCL-XL AND USES THEREOF ASIA VISION LIMITED (CN) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239792-A1 MODULATORS OF BCL-2 OR BCL-2/BCL-XL AND USES THEREOF BCL2, BCL2L2, BCL2L1 BCL2L1 3/4885BAD 15/4885TSHR 3700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.